Placenta‐derived exosomal miR‐135a‐5p promotes gestational diabetes mellitus pathogenesis by activating PI3K/AKT signalling pathway via SIRT1

Abstract

AbstractMost people are aware of gestational diabetes mellitus (GDM), a dangerous pregnancy complication in which pregnant women who have never been diagnosed with diabetes develop chronic hyperglycaemia. Exosomal microRNA (miRNA) dysregulation has been shown to be a key player in the pathophysiology of GDM. In this study, we looked into how placental exosomes and their miRNAs may contribute to GDM. When compared to exosomes from healthy pregnant women, it was discovered that miR‐135a‐5p was elevated in placenta‐derived exosomes that were isolated from the maternal peripheral plasma of GDM women. Additionally, we discovered that miR‐135a‐5p encouraged HTR‐8/SVneo cell growth, invasion and migration. Further research revealed that miR‐135a‐5p activates HTR‐8/SVneo cells' proliferation, invasion and migration by promoting PI3K/AKT pathway activity via Sirtuin 1 (SIRT1). The transfer of exosomal miR‐135a‐5p generated from the placenta could be viewed as a promising agent for targeting genes and pertinent pathways involved in GDM, according to our findings.